149 related articles for article (PubMed ID: 11369663)
1. Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha.
Schmidt M; Hochhaus A; Nitsche A; Hehlmann R; Neubauer A
Blood; 2001 Jun; 97(11):3648-50. PubMed ID: 11369663
[TBL] [Abstract][Full Text] [Related]
2. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
[TBL] [Abstract][Full Text] [Related]
3. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
Hao SX; Ren R
Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
[TBL] [Abstract][Full Text] [Related]
4. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
[TBL] [Abstract][Full Text] [Related]
5. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
Burchert A; Cai D; Hofbauer LC; Samuelsson MK; Slater EP; Duyster J; Ritter M; Hochhaus A; Müller R; Eilers M; Schmidt M; Neubauer A
Blood; 2004 May; 103(9):3480-9. PubMed ID: 14656881
[TBL] [Abstract][Full Text] [Related]
6. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
Tamura T; Kong HJ; Tunyaplin C; Tsujimura H; Calame K; Ozato K
Blood; 2003 Dec; 102(13):4547-54. PubMed ID: 12933588
[TBL] [Abstract][Full Text] [Related]
7. Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.
Hochhaus A; Yan XH; Willer A; Hehlmann R; Gordon MY; Goldman JM; Melo JV
Leukemia; 1997 Jul; 11(7):933-9. PubMed ID: 9204971
[TBL] [Abstract][Full Text] [Related]
8. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia.
Deng M; Daley GQ
Blood; 2001 Jun; 97(11):3491-7. PubMed ID: 11369642
[TBL] [Abstract][Full Text] [Related]
9. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
[TBL] [Abstract][Full Text] [Related]
10. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
[TBL] [Abstract][Full Text] [Related]
11. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
Hjort EE; Huang W; Hu L; Eklund EA
Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
[TBL] [Abstract][Full Text] [Related]
12. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
Tamura T; Ozato K
J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
[TBL] [Abstract][Full Text] [Related]
13. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein.
Scheller M; Foerster J; Heyworth CM; Waring JF; Löhler J; Gilmore GL; Shadduck RK; Dexter TM; Horak I
Blood; 1999 Dec; 94(11):3764-71. PubMed ID: 10572090
[TBL] [Abstract][Full Text] [Related]
14. Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemia.
Barthe C; Mahon FX; Gharbi MJ; Fabères C; Bilhou-Nabéra C; Hochhaus A; Reiffers J; Marit G
Blood; 2001 Jun; 97(11):3568-73. PubMed ID: 11369652
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.
Holtschke T; Löhler J; Kanno Y; Fehr T; Giese N; Rosenbauer F; Lou J; Knobeloch KP; Gabriele L; Waring JF; Bachmann MF; Zinkernagel RM; Morse HC; Ozato K; Horak I
Cell; 1996 Oct; 87(2):307-17. PubMed ID: 8861914
[TBL] [Abstract][Full Text] [Related]
16. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.
Huang W; Zhu C; Wang H; Horvath E; Eklund EA
J Biol Chem; 2008 Mar; 283(12):7921-35. PubMed ID: 18195016
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the antagonist effect of IFN-alpha on IFN-gamma-induced interferon consensus sequence binding protein messenger RNA in murine macrophages.
Fultz MJ; Vogel SN
J Inflamm; 1998; 48(1):28-39. PubMed ID: 9368190
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
Hochhaus A; Reiter A; Saussele S; Reichert A; Emig M; Kaeda J; Schultheis B; Berger U; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
Blood; 2000 Jan; 95(1):62-6. PubMed ID: 10607685
[TBL] [Abstract][Full Text] [Related]
20. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.
Wang IM; Contursi C; Masumi A; Ma X; Trinchieri G; Ozato K
J Immunol; 2000 Jul; 165(1):271-9. PubMed ID: 10861061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
